0.8739
Femasys Inc Aktie (FEMY) Neueste Nachrichten
Is Femasys Inc. a good long term investmentLightning-fast growth - Autocar Professional
What drives Femasys Inc. stock priceFree Expert Stock Watchlist - jammulinksnews.com
What analysts say about Femasys Inc. stockConsistent high-performance stocks - Autocar Professional
Femasys Faces Nasdaq Noncompliance Notice: Stock Price Below $1.00 for 30 Consecutive Business Days - AInvest
Femasys Inc. Stock Analysis and ForecastDynamic capital growth - jammulinksnews.com
Femasys Faces Nasdaq Noncompliance Notice for Stock Price - TipRanks
Femasys receives Nasdaq notice for minimum bid price noncompliance - Investing.com Australia
Femasys receives Nasdaq notice for minimum bid price noncompliance By Investing.com - Investing.com Nigeria
Why Femasys Inc. stock attracts strong analyst attentionTrend Based Entry Alerts - Newser
How Femasys Inc. stock performs during market volatilityShort Term Profit Focus - Newser
What makes Femasys Inc. stock price move sharplyVolume Spike Monitors - Newser
Femasys Enters Purchase Agreement with Alumni Capital - MSN
Femasys Secures $10 Million Financing with Alumni Capital Purchase Agreement - AInvest
Major Breakthrough: Australia and NZ Approve Femasys Revolutionary First-Line Infertility Solutions - Stock Titan
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic - The Manila Times
Femasys Gets Australia, New Zealand Approvals for Two Products - MarketScreener
Femasys stock rises as FemBloc gets CE Mark for permanent birth control - Investing.com
Femasys Receives European Approval for FemBloc Non-Surgical Permanent Birth Control - Femtech Insider
Femasys appoints Kelley Nicholas as chief commercial officer - Investing.com
Femasys appoints Kelley Nicholas as chief commercial officer By Investing.com - Investing.com Canada
Femasys Appoints Kelley Nicholas as Chief Commercial Officer - TipRanks
Femasys (FEMY) Appoints Kelley Nicholas as Chief Commercial Officer | FEMY Stock News - GuruFocus
Femasys appoints Nicholas as CCO - TipRanks
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth - GlobeNewswire
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates - MSN
40,968 Shares in Femasys Inc. (NASDAQ:FEMY) Acquired by Citadel Advisors LLC - Defense World
Femasys (NASDAQ:FEMY) Receives “Buy” Rating from HC Wainwright - Defense World
A Closer Look at Femasys Inc (FEMY) Stock Gains - investchronicle.com
The Analyst Verdict: Femasys In The Eyes Of 6 Experts - Benzinga
Femasys (FEMY): Buy Rating Reiterated by HC Wainwright & Co. | FEMY Stock News - GuruFocus
Femasys: Strategic Partnerships and Revenue Growth Drive Buy Rating with $12 Price Target - TipRanks
Femasys Announces Partnership with Carolinas Fertility - GlobeNewswire
Femasys announces partnership with Carolinas Fertility Institute - TipRanks
Femasys (FEMY) Partners with Carolinas Fertility Institute for FemaSeed Distribution | FEMY Stock News - GuruFocus
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):